Prescription drug costs can be a burden for many individuals, especially those without insurance or limited financial resources. Fortunately, GlaxoSmithKline (GSK) offers various programs and assistance options to help eligible patients access and afford the medications they need. In this comprehensive guide, we will explore the different GSK patient assistance programs, savings offers, co-pay assistance, and reimbursement support services. Whether you are uninsured, have Medicare, or face financial constraints, GSK strives to provide solutions that alleviate the financial burden of prescription medications.
GSK Patient Assistance Program for prescription medicines (non-vaccines)
To qualify for the GSK Patient Assistance Program, you must meet specific eligibility criteria. These criteria include:
- Uninsured: The program is available to individuals who do not have health insurance coverage
- Medicare: If you have Medicare, you may still be eligible for the program if you meet other requirements
- Residence: You must be a resident of the United States or Puerto Rico (or the US Virgin Islands for certain medicines)
- Financial Income: The program has financial income eligibility criteria that must be met to qualify
It’s important to note that patients enrolled in an Alternate Funding Program are not eligible for GSK PAP enrollment. Alternate Funding Programs are implemented by certain health insurance providers to divert resources intended for uninsured patients. Instead of providing coverage for certain medicines, these insurance providers require patients to apply to charitable patient assistance programs.
Alternate Funding Programs
Alternate Funding Programs, also known as Specialty Carve-Outs, are implemented by some health insurance providers through third-party vendors. These programs aim to utilize charitable patient assistance programs to redirect resources intended for uninsured patients. Instead of providing coverage for selected medications, the insurance providers require patients to apply to charitable patient assistance programs.
When a patient is approved for a patient assistance program, the cost of the medication shifts from the health insurance provider to the charitable organization. Both the health insurance provider and the third-party vendor profit from these programs. It’s crucial to understand the implications of Alternate Funding Programs and their impact on patients’ access to necessary medications.
Available drugs on the Patient Assistance Programme
Currently, the following drugs are available on the Patient Assistance Programme:
- ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder)
- ARNUITY ELLIPTA (fluticasone furoate inhalation powder)
- BENLYSTA (belimumab) Injection
- BREO ELLIPTA (fluticasone furoate and vilanterol inhalation powder)
- INCRUSE ELLIPTA (umeclidinium inhalation powder)
- JEMPERLI (dostarlimab)
- LAMICTAL (lamotrigine) Chewable Dispersible Tablets or Orally Disintegrating Tablets or Starter Kits
- LAMICTAL ODT (lamotrigine) Patient Titration Kits
- LAMICTAL XR (lamotrigine) extended-release tablets, for oral use or Patient Titration Kits
- MALARONE (atovaquone and proguanil hydrochloride) Tablets
- MEPRON (atovaquone) Suspension
- NUCALA (mepolizumab) for injection, for subcutaneous use
- OJJAARA (momelotinib) for oral use
- RELENZA (zanamivir) inhalation powder for oral inhalation
- SEREVENT DISKUS (salmeterol xinafoate inhalation powder)
- TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol inhalation powder), for oral inhalation
- ZEJULA (niraparib) for oral use
It’s important to note that this list may change periodically as GSK adds or removes medications from the program.
Recently discontinued products
It’s important to stay updated on the availability of medications through the GSK Patient Assistance Program. As of December 31, 2023, the following products will be fully removed from the program for all patients:
If you were previously receiving assistance for any of these products, it’s essential to explore alternative options and discuss them with your healthcare provider.
GSK Patient Assistance Program for vaccines
The GSK Patient Assistance Program for vaccines is designed to assist individuals who have no third-party coverage for vaccines and meet certain eligibility criteria. To qualify for the program, applicants must be adults aged 18 or older and reside in the United States or Puerto Rico. Additionally, individuals should not be eligible for Puerto Rico’s Government Health Plan Mi Salud or have been denied coverage under the plan.
Financial eligibility is determined based on household income, considering the number of individuals residing in the household. The income limits vary depending on the applicant’s location, with separate limits for the 48 contiguous states and the District of Columbia, Alaska, Hawaii, and Puerto Rico. The program’s income eligibility requirements ensure that assistance is targeted towards those who need it the most.
The following vaccines are currently included in the program:
- BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)
- ENGERIX-B [Hepatitis B Vaccine (Recombinant)]
- SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
Savings coupons and free trial offers
In addition to the Patient Assistance Program, GSK also offers savings coupons and free trial offers to help lower out-of-pocket costs for certain prescription medications. These offers can be particularly beneficial for individuals who may not qualify for the Patient Assistance Program or prefer to use coupons or free trials to manage their medication expenses.
To find savings offers and coupons for GSK medicines, patients can visit the GSK website or check the specific website dedicated to their prescribed medication. It’s important to note that savings offers and coupons are subject to eligibility criteria and may change or discontinue without prior notice. Patients are advised to regularly check the websites for updated information on available savings offers.
For individuals with commercial medical or prescription insurance plans, GSK offers a Co-pay Assistance Program to help with out-of-pocket costs for certain GSK prescription medicines. Eligible patients who have insurance coverage or are uninsured residents of the United States, including the District of Columbia, Puerto Rico, and the US Virgin Islands, may qualify for this program.
To determine eligibility and learn more about the terms and conditions of the Co-pay Assistance Program, patients can visit the GSK website. It’s important to note that the Co-pay Assistance Program is not a substitute for health insurance and is subject to change or discontinuation without notice.
Reimbursement support services
The GSK Reimbursement Resource Center (RRC) provides support to patients facing coverage and reimbursement issues for certain GSK products. The services offered by the RRC include benefits verification, prior authorization assistance, and resources to assist with out-of-pocket costs for specific GSK products.
To access the services provided by the RRC, patients can contact the center directly at 800-745-2967 from Monday to Friday between 8:30 AM and 8:00 PM ET. Alternatively, patients can also visit the GSK website for more information on reimbursement support services.
Accessing affordable prescription medications is a crucial aspect of healthcare management. GSK strives to support eligible patients by offering various assistance programs, savings coupons, co-pay assistance, and reimbursement support services. Whether you are uninsured, have Medicare, or face financial constraints, GSK’s commitment to providing affordable medications remains unwavering.
Patients are encouraged to explore the eligibility criteria and requirements for each program, regularly check for available savings offers and coupons, and stay informed about any changes to the program’s coverage. By taking advantage of these resources, individuals can alleviate the financial burden associated with prescription drug costs and focus on their overall well-being.
Remember, for more detailed information about each program and the medications they cover, visit the GSK website or speak with a healthcare professional. Your health and well-being are important, and GSK is here to support you on your journey towards affordable and accessible healthcare.
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information in this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
WHY WE BUILT NOWPATIENT
To improve the lives of everyone by making high-quality care accessible and convenient
We are here to improve lives. Our service gives you access to smart features and resources that can help empower you to take control of your health and improve your health outcomes. All this, in one place, for FREE. We strive to bring a fresh perspective to managing health. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Can I trust NowPatient
Meet our medical review team
Trustworthy and reliable medical content authored and reviewed by our experienced team of medical professionals from the United Kingdom and the United States. Learn more about our team and our editorial process by clicking on the buttons below.